Guangdong Zhongrun Pharmaceutical Research and Development

Guangdong Zhongrun Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of innovative drugs and high-end generic medicines. The company operates across several therapeutic areas, including immunology, metabolic diseases, and respiratory health, with a significant emphasis on monoclonal antibodies and small molecule inhibitors. Zhongrun Pharmaceutical maintains a robust R&D infrastructure and has established strategic partnerships to advance its pipeline through clinical trials in China. Its business model integrates drug discovery with a strong domestic sales and distribution network to bring advanced therapies to the Chinese market.